HomeCompareALYA vs MRK

ALYA vs MRK: Dividend Comparison 2026

ALYA yields 176.99% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ALYA wins by $11.8K in total portfolio value
10 years
ALYA
ALYA
● Live price
176.99%
Share price
$1.13
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$68.6K
Annual income
$60.20
Full ALYA calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — ALYA vs MRK

📍 ALYA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodALYAMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ALYA + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ALYA pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ALYA
Annual income on $10K today (after 15% tax)
$15,044.25/yr
After 10yr DRIP, annual income (after tax)
$51.17/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $8,277.24/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ALYA + MRK for your $10,000?

ALYA: 50%MRK: 50%
100% MRK50/50100% ALYA
Portfolio after 10yr
$62.7K
Annual income
$4,929.17/yr
Blended yield
7.86%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

ALYA
Analyst Ratings
1
Buy
1
Hold
Consensus: Buy
Price Target
$3.50
+209.7% upside vs current
Range: $3.50 — $3.50
Altman Z
1.1
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ALYA buys
0
MRK buys
0
No recent congressional trades found for ALYA or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricALYAMRK
Forward yield176.99%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%32.7%
Portfolio after 10y$68.6K$56.8K
Annual income after 10y$60.20$9,798.13
Total dividends collected$29.5K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy
Analyst price target$3.50$128.54

Year-by-year: ALYA vs MRK ($10,000, DRIP)

YearALYA PortfolioALYA Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$19,550$8,849.56$11,206$366.19+$8.3KALYA
2$29,002$8,084.34$12,650$502.35+$16.4KALYA
3$36,637$5,604.38$14,407$694.19+$22.2KALYA
4$42,510$3,308.26$16,585$967.82+$25.9KALYA
5$47,279$1,793.72$19,342$1,363.89+$27.9KALYA
6$51,521$932.23$22,913$1,947.19+$28.6KALYA
7$55,602$474.70$27,662$2,823.89+$27.9KALYA
8$59,734$239.40$34,159$4,173.35+$25.6KALYA
9$64,035$120.18$43,337$6,308.80+$20.7KALYA
10$68,578$60.20$56,776$9,798.13+$11.8KALYA

ALYA vs MRK: Complete Analysis 2026

ALYAStock

Alithya Group Inc. provides strategy and digital technology services in Canada, the United States, and Europe. The company's business strategy services include strategic consulting, digital transformation, organizational performance, and enterprise architecture services. It also provides application services, such as digital applications DevOps, legacy systems modernization, control and software engineering, cloud infrastructure, quality assurance, and automated testing; enterprise solutions comprising enterprise resource planning, corporate performance management, customer relationship management, and human capital management; and data and analytics solutions, including business intelligence, data management, artificial intelligence (AI), and machine learning, as well as internet of things. In addition, the company provides AI-FI, an integrated artificial intelligence and fidelity solution; Alithya GoTest, solution allows clients to test the functionality of applications on various platforms; CASSI analytics for online weekly maintenance, outage management, petrochemical turnarounds, and maintenance and reliability; and SIDER, a secure solution that facilitates distribution of medical results to healthcare sectors and to centralized electronic medical records. It serves financial services, energy, manufacturing, telecommunications, transportation and logistics, professional services, healthcare, and government sectors. Alithya Group Inc. was founded in 1992 and is headquartered in Montreal, Canada.

Full ALYA Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this ALYA vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ALYA vs SCHDALYA vs JEPIALYA vs OALYA vs KOALYA vs MAINALYA vs JNJALYA vs ABBVALYA vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.